Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification

Fangbing Liu, Nathalie Bloch, Kumar R. Bhushan, Alec M. De Grand, Eiichi Tanaka, Stephanie Solazzo, Pawel M. Mertyna, Nahum Goldberg, John V. Frangioni, Robert E. Lenkinski

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Microcalcifications are an important diagnostic marker for breast cancer on mammograms, yet the mechanism of their formation is poorly understood. Indeed, there is presently no short-latency, high-yield, syngeneic rodent model of the process. Bone morphogenetic protein 2 (BMP-2) is a key mediator of physiologic bone formation and pathologic vasculature calcification, but its role in breast cancer microcalcification is unknown. In this study, R3230 rat breast tumors were adapted to cell culture, transduced with adenoviral BMP-2, and inoculated into a syngeneic host. Tumor growth and calcium salt deposition were quantified in living animals over time using micro-computed tomography and probed chemically using nearinfrared fluorescence. Plasma BMP-2 levels were quantified over time by enzyme-linked immunosorbent assay. Within 3 weeks, 100% of the breast tumors developed microcalcifications, which were absent from all normal tissues. Importantly, when two tumors were initiated in a single host, the ipsilateral tumor expressing BMP-2 was able to induce microcalcification in the contralateral tumor that was not expressing BMP-2, suggesting that BMP-2 can act humorally. Taken together, we describe the first reproducible rodent model of breast cancer microcalcification, prove that BMP-2 expression is sufficient for initiating the process, and lay the foundation for a new generation of targeted diagnostic agents.

Original languageEnglish (US)
Pages (from-to)175-186
Number of pages12
JournalMolecular Imaging
Volume7
Issue number4
DOIs
StatePublished - Jul 2008

Fingerprint

Calcinosis
Bone Morphogenetic Protein 2
breast
bones
Bone
cancer
Breast Neoplasms
tumors
proteins
Proteins
Tumors
rodents
Rodentia
Neoplasms
osteogenesis
calcification
Osteogenesis
markers
rats
animals

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Biotechnology
  • Molecular Medicine
  • Biomedical Engineering
  • Condensed Matter Physics

Cite this

Liu, F., Bloch, N., Bhushan, K. R., De Grand, A. M., Tanaka, E., Solazzo, S., ... Lenkinski, R. E. (2008). Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification. Molecular Imaging, 7(4), 175-186. https://doi.org/10.2310/7290.2008.00018

Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification. / Liu, Fangbing; Bloch, Nathalie; Bhushan, Kumar R.; De Grand, Alec M.; Tanaka, Eiichi; Solazzo, Stephanie; Mertyna, Pawel M.; Goldberg, Nahum; Frangioni, John V.; Lenkinski, Robert E.

In: Molecular Imaging, Vol. 7, No. 4, 07.2008, p. 175-186.

Research output: Contribution to journalArticle

Liu, F, Bloch, N, Bhushan, KR, De Grand, AM, Tanaka, E, Solazzo, S, Mertyna, PM, Goldberg, N, Frangioni, JV & Lenkinski, RE 2008, 'Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification', Molecular Imaging, vol. 7, no. 4, pp. 175-186. https://doi.org/10.2310/7290.2008.00018
Liu, Fangbing ; Bloch, Nathalie ; Bhushan, Kumar R. ; De Grand, Alec M. ; Tanaka, Eiichi ; Solazzo, Stephanie ; Mertyna, Pawel M. ; Goldberg, Nahum ; Frangioni, John V. ; Lenkinski, Robert E. / Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification. In: Molecular Imaging. 2008 ; Vol. 7, No. 4. pp. 175-186.
@article{13e63b33dd974bb69cba10b8bd24aac6,
title = "Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification",
abstract = "Microcalcifications are an important diagnostic marker for breast cancer on mammograms, yet the mechanism of their formation is poorly understood. Indeed, there is presently no short-latency, high-yield, syngeneic rodent model of the process. Bone morphogenetic protein 2 (BMP-2) is a key mediator of physiologic bone formation and pathologic vasculature calcification, but its role in breast cancer microcalcification is unknown. In this study, R3230 rat breast tumors were adapted to cell culture, transduced with adenoviral BMP-2, and inoculated into a syngeneic host. Tumor growth and calcium salt deposition were quantified in living animals over time using micro-computed tomography and probed chemically using nearinfrared fluorescence. Plasma BMP-2 levels were quantified over time by enzyme-linked immunosorbent assay. Within 3 weeks, 100{\%} of the breast tumors developed microcalcifications, which were absent from all normal tissues. Importantly, when two tumors were initiated in a single host, the ipsilateral tumor expressing BMP-2 was able to induce microcalcification in the contralateral tumor that was not expressing BMP-2, suggesting that BMP-2 can act humorally. Taken together, we describe the first reproducible rodent model of breast cancer microcalcification, prove that BMP-2 expression is sufficient for initiating the process, and lay the foundation for a new generation of targeted diagnostic agents.",
author = "Fangbing Liu and Nathalie Bloch and Bhushan, {Kumar R.} and {De Grand}, {Alec M.} and Eiichi Tanaka and Stephanie Solazzo and Mertyna, {Pawel M.} and Nahum Goldberg and Frangioni, {John V.} and Lenkinski, {Robert E.}",
year = "2008",
month = "7",
doi = "10.2310/7290.2008.00018",
language = "English (US)",
volume = "7",
pages = "175--186",
journal = "Molecular Imaging",
issn = "1535-3508",
publisher = "Decker Publishing",
number = "4",

}

TY - JOUR

T1 - Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification

AU - Liu, Fangbing

AU - Bloch, Nathalie

AU - Bhushan, Kumar R.

AU - De Grand, Alec M.

AU - Tanaka, Eiichi

AU - Solazzo, Stephanie

AU - Mertyna, Pawel M.

AU - Goldberg, Nahum

AU - Frangioni, John V.

AU - Lenkinski, Robert E.

PY - 2008/7

Y1 - 2008/7

N2 - Microcalcifications are an important diagnostic marker for breast cancer on mammograms, yet the mechanism of their formation is poorly understood. Indeed, there is presently no short-latency, high-yield, syngeneic rodent model of the process. Bone morphogenetic protein 2 (BMP-2) is a key mediator of physiologic bone formation and pathologic vasculature calcification, but its role in breast cancer microcalcification is unknown. In this study, R3230 rat breast tumors were adapted to cell culture, transduced with adenoviral BMP-2, and inoculated into a syngeneic host. Tumor growth and calcium salt deposition were quantified in living animals over time using micro-computed tomography and probed chemically using nearinfrared fluorescence. Plasma BMP-2 levels were quantified over time by enzyme-linked immunosorbent assay. Within 3 weeks, 100% of the breast tumors developed microcalcifications, which were absent from all normal tissues. Importantly, when two tumors were initiated in a single host, the ipsilateral tumor expressing BMP-2 was able to induce microcalcification in the contralateral tumor that was not expressing BMP-2, suggesting that BMP-2 can act humorally. Taken together, we describe the first reproducible rodent model of breast cancer microcalcification, prove that BMP-2 expression is sufficient for initiating the process, and lay the foundation for a new generation of targeted diagnostic agents.

AB - Microcalcifications are an important diagnostic marker for breast cancer on mammograms, yet the mechanism of their formation is poorly understood. Indeed, there is presently no short-latency, high-yield, syngeneic rodent model of the process. Bone morphogenetic protein 2 (BMP-2) is a key mediator of physiologic bone formation and pathologic vasculature calcification, but its role in breast cancer microcalcification is unknown. In this study, R3230 rat breast tumors were adapted to cell culture, transduced with adenoviral BMP-2, and inoculated into a syngeneic host. Tumor growth and calcium salt deposition were quantified in living animals over time using micro-computed tomography and probed chemically using nearinfrared fluorescence. Plasma BMP-2 levels were quantified over time by enzyme-linked immunosorbent assay. Within 3 weeks, 100% of the breast tumors developed microcalcifications, which were absent from all normal tissues. Importantly, when two tumors were initiated in a single host, the ipsilateral tumor expressing BMP-2 was able to induce microcalcification in the contralateral tumor that was not expressing BMP-2, suggesting that BMP-2 can act humorally. Taken together, we describe the first reproducible rodent model of breast cancer microcalcification, prove that BMP-2 expression is sufficient for initiating the process, and lay the foundation for a new generation of targeted diagnostic agents.

UR - http://www.scopus.com/inward/record.url?scp=61949213192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61949213192&partnerID=8YFLogxK

U2 - 10.2310/7290.2008.00018

DO - 10.2310/7290.2008.00018

M3 - Article

C2 - 19123988

AN - SCOPUS:61949213192

VL - 7

SP - 175

EP - 186

JO - Molecular Imaging

JF - Molecular Imaging

SN - 1535-3508

IS - 4

ER -